Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery

doi 10.1021/acsami.6b16844.s001

Full Text

Abstract

Available in

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Telodendrimer Nanocarrier for Co-Delivery of Paclitaxel and Cisplatin: A Synergistic Combination Nanotherapy for Ovarian Cancer Treatment

Mechanics of Materials

English

Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity

Journal of Pharmaceutical Sciences

Pharmaceutical Science

English

Comparison of the Efficacy Between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

Cancer Research and Treatment

Cancer Research

English

In Vivo Evaluation of Doxorubicin-Loaded Polymeric Micelles Targeting Folate Receptors and Early Endosomal pH in Drug-Resistant Ovarian Cancer

Molecular Pharmaceutics

Molecular Medicine

Pharmaceutical Science

English

Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)

Japanese Journal of Urology

English

Mixed pH-Sensitive Polymeric Micelles for Combination Drug Delivery

Pharmaceutical Research

Organic Chemistry

Molecular Medicine

Pharmaceutical Science

Danish

Novel Polymer Micelle Mediated Co-Delivery of Doxorubicin and P-Glycoprotein siRNA for Reversal of Multidrug Resistance and Synergistic Tumor Therapy

Scientific Reports

Multidisciplinary

English

Phosphorylcholine Oligomer-Grafted Graphene Oxide for Tumor-Targeting Doxorubicin Delivery

Chemical Engineering

English

Role of Combination Chemotherapy With 5-Fluorouracil, Cisplatin and Paclitaxel for Advanced Gall Bladder Cancer

Journal of Cancer Therapy

English